PMID-30753815 – NNMT Inhibitor Activates Senescent Muscle Stem Cells
Neelakantan H, Vance V, Engel ML, McHardy SF, Watowich SJ, Bhatt DK. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat-diet-induced obesity in mice. Biochem Pharmacol. 2019;163:184-196.
Quick Reference
| Property | Value |
|---|---|
| PMID | 30753815 |
| DOI | 10.1016/j.bcp.2019.02.008 |
| Year | 2019 |
| Journal | Biochemical Pharmacology |
| Study Type | Animal in vivo |
| Evidence Level | V |
| Sample | Aged (24-month-old) C57BL/6 mice |
| Peptide(s) Studied | 5-Amino-1MQ |
Key Findings
- NNMT inhibition with 5-Amino-1MQ activated senescent muscle stem cells (satellite cells) in 24-month-old mice
- Treated aged mice showed approximately 2-fold greater muscle fiber cross-sectional area compared to controls
- Peak muscle torque was increased by approximately 70% in treated animals
- These results demonstrate that NNMT inhibition can reverse age-related muscle stem cell quiescence/senescence
- The findings extend 5-Amino-1MQ's therapeutic potential beyond obesity into sarcopenia and age-related muscle wasting
- Mechanism involves NNMT-mediated regulation of the NAD+ salvage pathway in muscle progenitor cells
Study Design
Aged (24-month-old) C57BL/6 mice — equivalent to approximately 70-year-old humans — received 5-Amino-1MQ treatment. Muscle stem cell activation was assessed by immunohistochemistry for satellite cell markers. Muscle fiber cross-sectional area was measured by histomorphometry. Functional outcomes were assessed by in situ measurement of peak isometric torque. Young adult mice served as reference controls.
Limitations
- Small sample size typical of aged mouse studies (aged mice are expensive and scarce)
- Short treatment duration — long-term effects on muscle maintenance unknown
- No assessment of whether functional gains translate to improved mobility or survival
- Aged mouse muscle may respond differently than human aged muscle
- No dose-response data for the muscle regeneration endpoint
- Mechanism of stem cell activation was proposed but not fully validated mechanistically
Clinical Relevance
This study is highly significant for the growing population of aging patients with sarcopenia. The ability to reactivate senescent muscle stem cells represents a fundamentally different approach from current sarcopenia treatments (exercise, protein supplementation, testosterone). The ~2-fold increase in fiber area and ~70% increase in peak torque are clinically meaningful effect sizes. If translatable to humans, 5-Amino-1MQ could become a first-in-class pharmacological treatment for age-related muscle loss. This also supports its use in anti-aging protocols alongside other longevity-focused peptides.
Related
#research #animal-in-vivo #5-Amino-1MQ #evidence-level-V